How can we help you today?
I want to book an appointment
I want to order repeat medication
I have an admin request
The pratice is closed, what do I do?
Non-urgent advice: Weight management medication
The current criteria is that patients are those with a BMI of 40 or higher, and with four or more of the qualifying comorbidities (hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes) will be eligible for assessment to identify their suitability for Mounjaro. Anyone not meeting these criteria will not be eligible for assessment in the first year of the drug being available.
Please do not contact your GP; if you are eligible to be assessed you will be contacted over the coming months and invited to attend an appointment for assessment. Those with the greatest clinical need will be contacted first.
For more information about alternative local weight management services, visit the ICS website – Local Weight Management services – Staffordshire and Stoke-on-Trent, ICS .
Your pharmacist can provide some prescription medicine for seven common conditions, if needed, without you needing to see a GP or have a prescription.
Phio is a free interactive online tool that quickly and accurately signposts you to the right pathway to support your MSK condition.
More information and advice
How do I
Other practice information
I can’t find what I’m looking for
See your medical history, order medication and more. See what you can do with the NHS App.
Tell us what we are doing well and let us know how we can improve. The Friends and Family test is completely anonymous.
Latest practice news
Get SPACE this summer
July 7, 2025The Space scheme is funded and co-ordinated by the Staffordshire Commissioner’s Office to provide an opportunity for Staffordshire Police and […]
Patient feedback June ’25
July 7, 2025Here are the results from the latest Friends and Family Test submissions (May ’25). If you would like to comment […]
Weight management medication
June 30, 2025From 23 June 2025, following approval by NICE, tirzepatide (known as Mounjaro®) will be available in the NHS for eligible […]